New York Delays Controversial Pharmacy Carve Out for Two Years
On April 6th, 2021, the New York legislature announced that it was delaying a controversial policy that would require the New York Medicaid program to
New Research Shows 340B Hospitals Provide More Medication Access Services Than Non-340B Hospitals
Below is a press release issued by CV340B highlighting new research showing that 340B hospitals provide more medication access services than non-340B
Op-ed by Prominent Community Leaders Highlights Severe Damage of New York’s Proposed Medicaid Carve-out
On March 23, an op-ed written by three prominent community leaders, Ms. Hazel Dukes, Rev Kirsten John Foy, and Rev Dr. Johnnie Green, was published in
Webinar: The Impact of Women in the 340B Drug Pricing Program
In this webinar sponsored by CV-340B, our panel of four exceptional leaders at the forefront of 340B will discuss the impact of women in 340B. The speakers
Bipartisan Group of Senators Reintroduce Bill to Protect Eligibility of 340B Hospitals During COVID-19 Pandemic
Last week, a bipartisan group of six senators, led by Senator John Thune (R-SD), reintroduced legislation (S. 773) that would allow disproportionate share
Indiana District Court Issues Order to Halt the 340B Administrative Dispute Resolution for Claims Against to Eli Lilly
On March 16, 2021, the U.S. District Court for the Southern District of Indiana issued an order granting Eli Lilly’s request for a preliminary injunction
HHS issues proposal to further delay the Trump Administration’s 340B insulin final rule
On March 9, 2021 the Department of Health and Human Services (HHS) issued a proposal to further delay implementation of the Trump Administration’s final
Express Scripts Issues 340B Claims Identification Requirements
Express Scripts, a large US-based PBM, announced a new 340B retrospective claims identification requirement. The new policy may impose significant burdens
PRESS STATEMENT: CV340B Names Advisory Council
March 2, 2021 PRESS STATEMENT: FOR IMMEDIATE RELEASE Contact: Peggy.Tighe@PowersLaw.com CV340B Names Advisory
226 Members of Congress Sign Letter Condemning Manufacturer Actions
In a letter, led by Representatives Spanberger, Axne, Matsui, McKinley, sent to Acting HHS Secretary Norris Cochran, 226 Members of Congress called on HHS